Cellectis S.A.
CLLS
$1.53
$0.021.33%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -36.76M | -84.48M | -78.91M | -65.34M | -101.06M |
| Total Depreciation and Amortization | 19.09M | 19.13M | 18.88M | 18.57M | 18.45M |
| Total Amortization of Deferred Charges | 758.00K | 69.00K | 69.00K | 69.00K | 69.00K |
| Total Other Non-Cash Items | -13.76M | 20.59M | -440.00K | -23.32M | 8.93M |
| Change in Net Operating Assets | 53.67M | 107.44M | 111.89M | 50.29M | 48.86M |
| Cash from Operations | 22.99M | 62.75M | 51.49M | -19.74M | -24.75M |
| Capital Expenditure | -2.58M | -2.31M | -1.85M | -1.08M | -1.07M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -100.23M | -97.49M | -120.59M | -16.71M | -14.44M |
| Cash from Investing | -102.81M | -99.80M | -122.43M | -17.79M | -15.51M |
| Total Debt Issued | 23.20M | 17.71M | 23.37M | 45.92M | 29.67M |
| Total Debt Repaid | -16.06M | -16.35M | -16.33M | -16.28M | -16.19M |
| Issuance of Common Stock | 83.24M | 129.40M | 129.40M | 46.56M | 71.39M |
| Repurchase of Common Stock | -207.00K | -207.00K | -1.40M | -1.40M | -1.40M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -1.05M | -2.78M | -1.37M | 187.00K | -600.00K |
| Cash from Financing | 89.11M | 127.77M | 133.67M | 74.98M | 82.87M |
| Foreign Exchange rate Adjustments | -2.75M | 1.01M | 1.93M | -52.00K | 884.00K |
| Miscellaneous Cash Flow Adjustments | 1.00K | -1.00K | -1.00K | -1.00K | -1.00K |
| Net Change in Cash | 6.54M | 91.73M | 64.66M | 37.40M | 43.49M |